Company Filing History:
Years Active: 2003
Title: Bengt Hallen: Innovator in Pharmaceutical Formulations
Introduction
Bengt Hallen is a notable inventor based in Sollentuna, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations that enhance drug delivery and efficacy.
Latest Patents
Hallen holds a patent for a pharmaceutical formulation that includes tolterodine or a related compound. This formulation is designed to exhibit a controlled in vitro release of the active ingredient, achieving not less than about 80% release in phosphate buffer at pH 6.8 after 18 hours. Furthermore, after oral administration, it is capable of maintaining a substantially constant serum level of the active moiety for 24 hours. This invention is particularly useful for treating overactive bladder and gastrointestinal disorders.
Career Highlights
Bengt Hallen has worked with Pharmacia AB, where he has been instrumental in advancing pharmaceutical research and development. His innovative approach has led to the creation of effective treatments that address significant health issues.
Collaborations
Hallen has collaborated with notable colleagues, including Lisbeth Nilvebrant and Birgitta Olsson, contributing to a dynamic research environment that fosters innovation and excellence in pharmaceutical sciences.
Conclusion
Bengt Hallen's work in pharmaceutical formulations exemplifies the impact of innovation in healthcare. His contributions continue to influence the development of effective treatments for various medical conditions.